The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global genomics market was valued at US$ 25.11 Billion in 2021.
We expect the global genomics market to exhibit a CAGR of 15.54% during 2022-2027.
The extensive utilization of genomics for research activities and finalizing treatment options for
numerous diseases, such as Alzheimer's, diabetes, cancer, etc., is primarily driving the global
The sudden outbreak of the COVID-19 pandemic has led to the increasing adoption of genomics to
study the impact of the coronavirus infection and develop vaccines, drugs, and testing kits for its
Based on the component, the global genomics market has been divided into products and services,
where products, including consumables and reagents currently exhibit a clear dominance in the
Based on the application, the global genomics market can be categorized into functional genomics,
epigenomics, biomarkers discovery, pathway analysis, and others. Currently, functional genomics
hold the majority of the total market share.
Based on the technology, the global genomics market has been segmented into sequencing,
microarray, polymerase chain reaction, nucleic acid extraction and purification, and others. Among
these, sequencing represents the largest market share.
Based on the end-user, the global genomics market can be bifurcated into research centers,
hospitals and clinics, pharmaceutical and biotechnology companies, and others. Currently,
pharmaceutical and biotechnology companies account for the majority of the total market share.
On a regional level, the market has been classified into North America, Europe, Asia Pacific, Middle
East and Africa, and Latin America, where North America currently dominates the global market.
Some of the major players in the global genomics market include 23andMe, Inc, Agilent
Technologies, Inc., Bayer AG, BGI Group, Bio-Rad Laboratories, Inc., Danaher Corporation, Illumina,
Inc., Oxford Nanopore Technologies, PerkinElmer, Inc., Myriad Genetics, Inc., F. Hoffmann-La Roche
Ltd, and Thermo Fisher Scientific Inc.
Gastric Cancer Drugs Market by Type (Doxorubicin hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib, Trastuzumab), Route of Administration (Oral, Parenteral), End User (Hospitals, Clinics, and Others), and Region 2023-2028
Immunotherapy Drugs Market by Type (Monoclonal Antibodies, Vaccines, Interferons Alpha and Beta, Interleukins), Therapy Area (Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases, and Others), End User (Hospitals, Clinics, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at